abrdn Life Sciences Investors (HQL): SCHEDULE 13D/A filed Feb 23, 2026

Form type

SCHEDULE 13D/A

Filing date

Feb 23, 2026

Accession number

0001062993-26-001121

Filer

abrdn Life Sciences Investors (CIK 884121)